Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 12Brain Neoplasms 7Medulloblastoma 4Central Nervous System Neoplasms 4Astrocytoma 4Glioma 3Recurrence 2Neoplasms 2Spinal Cord Neoplasms 1Lymphoma, AIDS-Related 1Gliosarcoma 1

Interventions

Temozolomide 4Carboplatin 3Bevacizumab 3Radiotherapy 2Immunoglobulin G 2Disulfides 2etoposide phosphate 1Vorinostat 1Vincristine 1Surveys and Questionnaires 1Standard of Care 1Radiosurgery 1Radiation 1Microarray Analysis 1Lomustine 1Lapatinib 1Irinotecan 1Immunohistochemistry 1Ifosfamide 1Fluorodeoxyglucose F18 1Erlotinib Hydrochloride 1Donepezil 1Dasatinib 1Cryosurgery 1Blotting, Western 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Spinal Cord Neoplasms × Lomustine × Clear all
NCT00100802 2023-02-15

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Children's Oncology Group

Phase 2 Completed
118 enrolled 8 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡